VEKLURY® is a prescription medicine used to treat COVID-19 in adults and children weighing at least 3 pounds who are hospitalized; or not hospitalized and have mild-to-moderate COVID-19, and are at high risk for progression to severe COVID-19, including hospitalization or death. Talk to a healthcare provider to see if VEKLURY may be an option for you.
Gilead's Advancing Access® program provides support resources for you and your loved ones
The Advancing Access program can help you understand how to access your prescribed VEKLURY and determine if any financial support options are available for you.
General inquiries
Our program specialists can answer questions about accessing your prescribed VEKLURY and help determine available resources and next steps.
Insurance verification
Our program specialists can gather information about your insurance coverage for VEKLURY, for outpatient use.
Financial support resources
Our program specialists can see what financial support options are available, such as our co-pay coupon program for commercially insured eligible patients or Patient Assistance Program (PAP) for uninsured patients prescribed VEKLURY in the outpatient setting.
An Advancing Access program specialist is available if you need further assistance, want more information, or have questions.
Call 1-800-226-2056 (Option 4) Monday through Friday, 9 AM to 8 PM ET. You can also leave a confidential message any time and day of the week.
Additional VEKLURY and COVID-19 resources
To find outpatient clinics where VEKLURY is administered, please use the US Department of Health and Human Services (DHHS) COVID-19 Therapeutics Locator
Learn more about VEKLURY
Download the brochure for more information
IMPORTANT SAFETY INFORMATION
Who should not take VEKLURY?
Do not take VEKLURY if you:
- Are allergic to remdesivir or any of the other ingredients in VEKLURY.
What are the possible side effects of VEKLURY?
Serious side effects of VEKLURY may include:
- Allergic reactions. VEKLURY can cause allergic reactions during or after infusion. Tell your healthcare provider right away if you get any of the following symptoms: changes to heart rate, rash, fever, nausea, sweating, shortness of breath, or wheezing, or swelling of the lips, face, or throat.
- Increase in liver enzymes. Increases in the amount of liver enzymes are common in people who have received VEKLURY and may be a sign of liver injury. Your healthcare provider will do blood tests to check your liver enzymes before and during treatment and may stop your treatment with VEKLURY if you develop new or worsening liver problems.
The most common side effect in people receiving VEKLURY is nausea. Tell your healthcare provider if you have any side effects that bother you or do not go away.
What should I tell my healthcare provider before receiving VEKLURY?
- All your health problems. Be sure to tell your healthcare provider if you have or have had any allergies, liver problems, or any serious illnesses.
- If you are pregnant or breastfeeding: It is not known if VEKLURY may harm your unborn baby if taken during the first trimester. VEKLURY can pass into your breast milk. If you are pregnant or breastfeeding, discuss your options and specific situation with your healthcare provider.
- All the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Other medicines may affect how VEKLURY works. Especially tell your healthcare provider if you are taking any medicines that contain chloroquine phosphate or hydroxychloroquine sulfate.
How is VEKLURY given?
- Hospitalized: VEKLURY is given to you through a vein by intravenous (IV) infusion one time each day for up to 10 days. Your healthcare provider will decide how many doses you need.
- Not hospitalized: VEKLURY is given to you through a vein by IV infusion one time each day for 3 days.
WHAT IS VEKLURY?
VEKLURY is a prescription medicine used to treat COVID-19 in adults and children weighing at least 3 pounds who are:
- Hospitalized, or
- Not hospitalized and have mild-to-moderate COVID-19, and are at high risk for progression to severe COVID-19, including hospitalization or death.
Talk to a healthcare provider to see if VEKLURY may be an option for you.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch, or call 1-800-FDA-10881-800-FDA-1088.
Please see Patient Prescribing Information for VEKLURY.